Thus, GLS2 expression proved to be diminished in colon tumor tissues compared to adjacent non-tumor tissues and, as in the case of HCC, promoter methylation was found to be a key mechanism underlying GLS2 silencing in colon cancer. Here, GLS2 is linked to malignant colon neoplasm.